Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
12/2003
12/17/2003EP0954580B1 Human sdf-5 protein and compositions
12/17/2003EP0922101B1 Egf-like factor from chromaffin granules and glia cell-derived neurotrophic factor with survival-promoting activity on daergic neurons
12/17/2003EP0917580B1 DEFORMYLATION OF f-MET PEPTIDES IN BACTERIAL EXPRESSION SYSTEMS
12/17/2003EP0805867B1 Dna integration by transposition
12/17/2003EP0795005B1 New e.coli mutant with suppressed organic acid production
12/17/2003EP0792363B1 Novel pesticidal proteins and strains
12/17/2003EP0763101B1 Nucleic acid sequences and expression systems for heparinase iii derived from flavobacterium heparinum
12/17/2003EP0672131B1 A novel cell cycle control protein
12/17/2003EP0571387B1 A non-mitogenic competitive hgf antagonist
12/17/2003EP0424437B1 Recombinant mycobacterial expression vehicles and uses therefor
12/17/2003CN1462309A Codon-optimized papilloma virus sequences
12/17/2003CN1462308A Nucleotide sequences which code lysRs gene
12/17/2003CN1461807A Fermentation method of producing antifungus active substance using ocean streptomycete
12/17/2003CN1131315C Prodn. of trehalos in plant
12/17/2003CN1131313C Promoters for gene expression
12/17/2003CN1131312C N-teminally extended proteins expressed in yeast
12/17/2003CN1131309C IL-6 mutein
12/16/2003US6664387 Expression cassette and plasmid for strong constitutive gene expression and the use thereof
12/16/2003US6664385 Kidney injury-related molecules
12/16/2003US6664376 Chimeric polypeptide molecules
12/16/2003US6664375 Nucleotide sequences coding binding protein for use in the treatment of alzheimer's disease and nervous system disorders
12/16/2003US6664370 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
12/16/2003US6664105 Polynucleotide encoding a polypeptide having heparanase activity and expression of same in genetically modified cells
12/16/2003US6664103 Chemically assembled nano-scale circuit elements
12/16/2003US6664102 Fungal degradation and bioremediation system for creosote-treated wood
12/16/2003US6664099 Method for the preservation of viruses and mycoplasma
12/16/2003US6664097 Polynucleotide encoding a Lactobacillus gasseri beta-glucuronidase polypeptide
12/16/2003US6664096 Nutrient broths for use in the propagation of microorganism
12/16/2003US6664095 Solid state fermentation
12/16/2003US6664092 Nucleic acid sequences; amino acid sequences; vectors; host cells; genetic engineering; Aspergillus oryzae; use in the production of protein hydrolysates having desirable organoleptic properties and high degrees of hydrolysis
12/16/2003US6664090 Carboxylesterase nucleic acid molecules, proteins and uses thereof
12/16/2003US6664082 Microorganism belonging to the genus Gluconobacter, which has an engineered gene for the biological activity of reducing L-sorbose which is more than 90% non- functional in developing the said biological activity.
12/16/2003US6664078 Culturing a bacterial transformant in an antibiotic-free batch medium and feeding the portion of a feed-back medium after the rise of the concentration of dissolved oxigen above a threshold-set point; isolation of ccc plasmid DNA
12/16/2003US6664076 Modification of bacteria
12/16/2003US6664049 Causing a mixture of nucleated cells and lysing agent to flow in a steady stream inside a tube; flow rate being adjusted as a function of the diameter and of the length of the tubing as to obtain a homegenous cell lysate
12/16/2003US6664048 Combination of selection steps used to detect clones that express interacting molecules from false positive clones.
12/16/2003US6663906 Expression of fructose 1,6 bisphosphate aldolase in transgenic plants
12/16/2003US6663872 Immune response
12/16/2003US6663868 Heat shock protein-based vaccines and immunotherapies
12/16/2003CA2201314C Microbiological parts washer
12/16/2003CA2096604C Protein c derivatives
12/14/2003CA2430259A1 Vaccine
12/11/2003WO2003102221A1 Screening method for regulatory enzymes employing tribrid (tri-hybrid) system
12/11/2003WO2003102217A2 Synthesis of cis-diols from aryl silanes
12/11/2003WO2003102213A2 Error-prone dna polymerase i mutants and methods for targeted random mutagenesis in continuous culture using error-prone dna polymerase i mutants
12/11/2003WO2003102204A2 Streptococcus thermophilus strain producing exopolysaccharide
12/11/2003WO2003102201A2 Methods and materials for the production of d-lactic acid in yeast
12/11/2003WO2003102200A2 Fermentation process using specific oxygen uptake rates as a process control
12/11/2003WO2003102194A1 Chondroitin synthetase and dna coding for the enzyme
12/11/2003WO2003102193A1 Chondroitin synthetase and nucleic acid coding for the enzyme
12/11/2003WO2003102192A1 Methods of purification of cytochrome p450 proteins and of their crystallizing
12/11/2003WO2003102191A1 Immunogenic sequences
12/11/2003WO2003102190A2 Bacterial polypeptides involved in viability
12/11/2003WO2003102189A1 Allergen from mugwort pollen
12/11/2003WO2003102188A1 Mutated androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof
12/11/2003WO2003102187A1 Self-coalescing or self-aggregating proteins derived from a membrane translocating sequence
12/11/2003WO2003102184A1 Methods, compositions and kits for cell separation
12/11/2003WO2003102182A1 Inflammatory skin disease-related slurp-2 gene and utilization thereof
12/11/2003WO2003102177A1 METHOD OF SCREENING COMPOUND AFFECTING AMYLOID β PRODUCTION
12/11/2003WO2003102174A2 Modified phytases
12/11/2003WO2003102170A1 Strains of bordetella made deficient by means of genetic attenuation
12/11/2003WO2003102169A1 Anaerobe targeted enzyme-mediated prodrug therapy
12/11/2003WO2003102168A1 Attenuated listeria spp. and methods for using the same
12/11/2003WO2003102167A1 Method of culturing animal planktons
12/11/2003WO2003102157A2 Synthetic antibody phage libraries
12/11/2003WO2003102155A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/11/2003WO2003102152A2 Methods and materials for the production of lactic acid in yeast
12/11/2003WO2003102138A2 Elongase genes and uses thereof
12/11/2003WO2003102135A2 Control sequences of the human corin gene
12/11/2003WO2003102128A1 Maize nucleotide sequence coding for a protein with transglutaminase activity and use thereof
12/11/2003WO2003102127A2 Human 5-ht7 receptor promoter sequence
12/11/2003WO2003102028A1 Rb1 gene induced protein (rb1cc1) and gene
12/11/2003WO2003101399A2 Novel bacterium for treatment of disease
12/11/2003WO2003101388A2 Human solute carrier family 7 member 11 (hslc7a11)
12/11/2003WO2003101386A2 Kinase suppressor of ras inactivation for therapy of ras mediated tumorigenesis
12/11/2003WO2003076463A3 Listeria monocytogenes ctsr mutants presenting low virulence and stress-resistance
12/11/2003WO2003070265A3 Hedgehog-related prophylaxis, therapy and diagnosis of gi tract carcinogenesis
12/11/2003WO2003064590A3 Microfluidic systems and methods for transport and lysis of cells and analysis of cell lysate
12/11/2003WO2003057861A3 Sulfur-oxidizing bacteria for promoting plant growth
12/11/2003WO2003048306A3 Polycistronic expression of antibodies
12/11/2003WO2003044048A3 Methylated heparin-binding hemagglutinin (hbha) recombinant mycobacterial antigen
12/11/2003WO2003035827A3 Plasticized hydrophilic glasses for improved stabilization of biological agents
12/11/2003WO2003029458A3 Method for producing protein libraries and for selecting proteins from said libraries
12/11/2003WO2003029407A3 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof
12/11/2003WO2003025218A3 Methods and yeast strains for screening antifungal agents
12/11/2003WO2003025132A3 Dna polymerases and mutants thereof
12/11/2003WO2003014370A3 Process for the fermentative preparation of l-amino acids using coryneform bacteria
12/11/2003WO2003006671A3 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
12/11/2003WO2003006656A3 Process for the preparation of 2,4-dideoxyhexoses and 2,4,6-trideoxyhexoses
12/11/2003WO2003002730A3 Method for detecting calpain 3 activity in a biological sample and peptides for implementing said method
12/11/2003WO2003000727A3 Atopy
12/11/2003WO2002101064A3 Process for the preparation of d-pantothenic acid and/or salts thereof
12/11/2003WO2002097096A3 Nucleotide sequences which code for the metd gene
12/11/2003WO2002088305A3 Isolation and identification of mouse and human transcription control elements associated with cytochrome expression
12/11/2003WO2002083841A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
12/11/2003WO2002081658A3 Transgenic mice containing cacnb4 calcium ion channel gene disruptions
12/11/2003WO2002075507B1 Anti-bacterial vaccine compositions
12/11/2003WO2002067986A3 Symbiotic regenerative agent
12/11/2003WO2002065943A3 Ocular tear growth factor-like protein
12/11/2003WO2002064788A3 Compositions and methods relating to lung specific genes and proteins
1 ... 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 ... 1489